GSK wins $3.0-bln takeover of Human Genome Sciences
British drugmaker GlaxoSmithKline on Monday clinched the takeover of US research partner Human Genome Sciences Inc. after increasing its bid to $3.0 billion (2.4 billion euros).
Good Health is Your Greatest Wealth……Virgil
British drugmaker GlaxoSmithKline on Monday clinched the takeover of US research partner Human Genome Sciences Inc. after increasing its bid to $3.0 billion (2.4 billion euros).